René-Olivier Casasnovas Selected Research

René-Olivier Casasnovas Research Topics

Disease

11	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 05/2007
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 11/2013
8	Neoplasms (Cancer) 01/2022 - 10/2016
6	Lymphoma (Lymphomas) 02/2024 - 03/2017
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 01/2020
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2021 - 11/2013
2	Fatigue 01/2020 - 01/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 02/2015
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2018 - 01/2018
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2024
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022
1	Residual Neoplasm 12/2021
1	Infections 01/2021
1	Obesity 01/2019
1	Infertility (Sterility) 01/2019
1	Circulating Neoplastic Cells 10/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Lymphadenopathy 10/2017

Drug/Important Bio-Agent (IBA)

5	Rituximab (Mabthera)FDA Link 02/2024 - 11/2013
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2023 - 04/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 01/2019
3	Vinblastine (Vinblastine Sulfate)FDA Link 10/2023 - 01/2019
3	Dacarbazine (DIC)FDA LinkGeneric 10/2023 - 01/2019
3	Circulating Tumor DNAIBA 12/2021 - 10/2018
3	Cell-Free Nucleic AcidsIBA 12/2021 - 10/2018
2	Brentuximab VedotinIBA 10/2023 - 06/2018
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2019
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 01/2020
2	Bendamustine Hydrochloride FDA Link 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2018
2	Lenalidomide (CC 5013)FDA Link 10/2021 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 01/2019
1	Chlorambucil (Leukeran)FDA Link 02/2024
1	axicabtagene ciloleucelIBA 10/2022
1	tisagenlecleucelIBA 10/2022
1	romidepsin (FK228)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	parsaclisibIBA 01/2021
1	obinutuzumabIBA 01/2021
1	Carmustine (FIVB)FDA Link 01/2020
1	Melphalan (Alkeran)FDA LinkGeneric 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2019
1	Procarbazine (Matulane)FDA Link 01/2019
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 10/2017
1	Monoclonal AntibodiesIBA 02/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2013
1	Gemcitabine FDA Link 11/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007
1	Interleukin-6 (Interleukin 6)IBA 05/2007
1	CytokinesIBA 05/2007
1	Type II Tumor Necrosis Factor ReceptorsIBA 05/2007
1	Interleukin-10 (Interleukin 10)IBA 05/2007

Therapy/Procedure

12	Therapeutics 11/2023 - 11/2013
6	Drug Therapy (Chemotherapy) 01/2022 - 04/2014
3	Stem Cell Transplantation 01/2022 - 06/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Radiotherapy 01/2021
1	Transplantation 01/2020
1	BEAM regimen 01/2020
1	Induction Chemotherapy 01/2020
1	Aftercare (After-Treatment) 01/2017